machine learning pipeline (KNIME GmbH)
90
Structured Review
KNIME GmbH
machine learning pipeline
Machine Learning Pipeline, supplied by KNIME GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/machine+learning+algorithm/machine+learning+algorithms/pm37061207-61-1-7
Average 90 stars, based on 1 article reviews
Machine Learning Pipeline, supplied by KNIME GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/machine+learning+algorithm/machine+learning+algorithms/pm37061207-61-1-7
Average 90 stars, based on 1 article reviews
machine learning pipeline - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Predicting total healthcare demand using machine learning: separate and combined analysis of predisposing, enabling, and need factors. Article Snippet: Binding Assay:Article Title: Prediction of Peptide and TCR CDR3 Loops in Formation of Class I MHC-Peptide-TCR Complexes Using Molecular Models with Solvation Article Snippet: .. These parameters are used to develop a Immunopeptidomics:Article Title: Prediction of Peptide and TCR CDR3 Loops in Formation of Class I MHC-Peptide-TCR Complexes Using Molecular Models with Solvation Article Snippet: .. These parameters are used to develop a Functional Assay:Article Title: Will the hype of automated drug discovery finally be realized? Article Snippet: More importantly, KNIME also supports many programming languages including Python, R and Bash, which facilitate the users’ general tasks. .. Furthermore, most Generated:Article Title: Optimizing kinase and PARP inhibitor combinations through machine learning and in silico approaches for targeted brain cancer therapy. Article Snippet: The drug combination is an attractive approach for cancer treatment.. PARP and kinase inhibitors have recently been explored against cancer cells, but their combination has not been investigated comprehensively.. In this study, we used various drug combination databases to build ML models for drug combinations against brain cancer cells. |